UPDATED Jul 22, 2024
Explore the French (CAC) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
DIM | €145.35 | -1.0% | -46.7% | €14.1b | €231.08 | PE83.4x | E30.0% | 0.5% | ||
BOI | €31.50 | -3.4% | -37.5% | €546.9m | €39.60 | PE15.3x | E14.1% | 4.3% | ||
ABVX | €11.52 | -1.0% | -34.4% | €724.8m | €36.34 | PS161.3x | E6.5% | n/a | ||
ADOC | €6.05 | -2.9% | 35.8% | €91.0m | €6.30 | PS15x | E63.0% | n/a | ||
OSE | €6.46 | -1.7% | 87.5% | €140.5m | €10.15 | PS63.1x | E5.9% | n/a | ||
ALDVI | €1.16 | -6.3% | -67.8% | €14.2m | €6.90 | PS4.3x | E117.3% | n/a | ||
IVA | €2.49 | -0.6% | -28.5% | €130.1m | €13.84 | PS5.6x | E20.3% | n/a | ||
ALOPM | €1.20 | -2.4% | -20.0% | €21.8m | €2.48 | PS12.5x | E0.04% | n/a | ||
ALCOX | €0.17 | -4.4% | -60.9% | €10.9m | €1.00 | PS3.1x | E16.1% | n/a | ||
NANO | €4.77 | -0.2% | -44.1% | €226.1m | €11.68 | PS6.2x | E23.7% | n/a | ||
ALACT | €0.55 | -3.2% | -90.1% | €8.6m | €1.00 | PE-0.5x | E108.4% | n/a | ||
GNRO | €0.087 | -8.2% | -94.6% | €2.6m | €2.05 | PE-0.2x | E-37.3% | n/a | ||
TNG | €1.12 | -0.2% | -38.6% | €112.8m | €2.60 | PS14.3x | E-30.4% | n/a | ||
PHXM | €1.95 | -0.8% | -67.7% | €19.5m | €5.10 | PS14.7x | E6.2% | n/a | ||
ALNFL | €2.33 | -0.4% | -9.9% | €22.6m | €4.20 | n/a | n/a | n/a | ||
POXEL | €0.51 | -0.2% | -22.6% | €24.9m | n/a | PS16.1x | n/a | n/a | ||
ALVIO | €0.10 | -0.2% | -59.4% | €15.4m | €1.20 | PS8.5x | n/a | n/a | ||
ALVET | €0.28 | -3.1% | -83.0% | €902.7k | n/a | PB0.1x | n/a | n/a | ||
ALPHA | €0.0005 | -44.4% | -100.0% | €86.0 | n/a | PE-0.000003x | n/a | n/a | ||
GV | €0.0018 | 0% | -91.3% | €692.9k | n/a | PE-0.07x | n/a | n/a | ||
AB | €1.06 | 0% | -74.4% | €62.8m | €6.90 | PS64.7x | E-8.6% | n/a | ||
ALPHE | €2.00 | 0% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
ALPRE | €6.20 | 0% | 5.1% | €22.9m | n/a | PS72.2x | n/a | n/a | ||
PCA | €8.00 | 0% | 11.1% | €109.9m | n/a | PE12.5x | n/a | 0% |